Bright Minds Biosciences ...
(DRUG)
undefined
undefined%
At close: undefined
41.45
0.61%
After-hours Dec 13, 2024, 04:16 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Net Income | -7.37M | -14.96M | -8.65M | -480.38K | -78.72K |
Depreciation & Amortization | 72.45K | 6.04K | - | - | - |
Stock-Based Compensation | 1.15M | 875.06K | 880.62K | 161.30K | - |
Other Working Capital | -941.72K | 771.94K | 416.23K | 30.68K | 36.71K |
Other Non-Cash Items | 65.10K | -229.57K | 144.76K | 161.30K | 110.12K |
Deferred Income Tax | - | - | - | - | - |
Change in Working Capital | -941.72K | 726.31K | 306.08K | 30.68K | 36.71K |
Operating Cash Flow | -7.02M | -13.59M | -7.32M | -288.39K | -42.01K |
Capital Expenditures | 5.00 | - | - | - | - |
Acquisitions | - | - | - | - | - |
Purchase of Investments | - | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | - |
Other Investing Acitivies | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Debt Repayment | -86.11K | -7.16K | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Dividend Paid | - | - | - | - | - |
Other Financial Acitivies | 1.06M | 1.17M | -1.69M | - | 366.00K |
Financial Cash Flow | 2.19M | 5.20M | 26.06M | 1.01M | 122.00K |
Net Cash Flow | -4.88M | -8.13M | 18.96M | 719.94K | 79.99K |
Free Cash Flow | -7.02M | -13.59M | -7.32M | -288.39K | -42.01K |